179 related articles for article (PubMed ID: 20713833)
41. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
Tzung TY; Chen CY; Yang CY; Lo PY; Chen YH
Acta Derm Venereol; 2008; 88(3):279-80. PubMed ID: 18480933
[No Abstract] [Full Text] [Related]
42. Long-term treatment of psoriasis with calcipotriol scalp solution and cream.
Barnes L; Altmeyer P; Fôrstrôm L; Stenström MH
Eur J Dermatol; 2000; 10(3):199-204. PubMed ID: 10725818
[TBL] [Abstract][Full Text] [Related]
43. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
44. Calcipotriol ointment under occlusion gives a fast onset of action.
Hindsén M; Traulsen J
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):764-5. PubMed ID: 16836527
[No Abstract] [Full Text] [Related]
45. [New treatment of psoriasis with the vitamin D analogue calcipotriol].
Austad J
Tidsskr Nor Laegeforen; 1993 Nov; 113(29):3580-1. PubMed ID: 8273098
[TBL] [Abstract][Full Text] [Related]
46. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
Saraceno R; Andreassi L; Ayala F; Bongiorno MR; Giannetti A; Lisi P; Martini P; Peris K; Peserico A; Chimenti S
J Dermatolog Treat; 2007; 18(6):361-5. PubMed ID: 17934937
[TBL] [Abstract][Full Text] [Related]
47. Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.
Charakida A; Dadzie O; Teixeira F; Charakida M; Evangelou G; Chu AC
Expert Opin Pharmacother; 2006 Apr; 7(5):597-606. PubMed ID: 16553575
[TBL] [Abstract][Full Text] [Related]
48. Once daily application of a combination of calcipotriol and betamethasone dipropionate (Dovobet, Daivobet) for the treatment of psoriasis.
Lui H; Shapiro J
Skin Therapy Lett; 2003; 8(Suppl 1):1-2. PubMed ID: 14961173
[TBL] [Abstract][Full Text] [Related]
49. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of calcipotriol in psoriasis.
Br J Clin Pract Suppl; 1996 Feb; 83():8-25. PubMed ID: 8871485
[No Abstract] [Full Text] [Related]
51. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
Pariser DM; Pariser RJ; Breneman D; Lebwohl M; Kalb R; Moore J; Moss H; Parker C; Fiedler V
Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897
[No Abstract] [Full Text] [Related]
52. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.
Koo J
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S59-61. PubMed ID: 9344187
[TBL] [Abstract][Full Text] [Related]
53. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
54. Calcipotriol. A new topical antipsoriatic.
Kragballe K; Iversen L
Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
[TBL] [Abstract][Full Text] [Related]
55. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
[TBL] [Abstract][Full Text] [Related]
56. A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study.
Marchetti A; LaPensee K; An P
Clin Ther; 1998; 20(4):851-69. PubMed ID: 9737842
[TBL] [Abstract][Full Text] [Related]
57. Comparison of calcipotriene (Dovonex) with a coal tar emulsion (Exorex) in treating psoriasis in adults: a pilot study.
Veronikis IE; Malabanan AO; Holick MF
Arch Dermatol; 1999 Apr; 135(4):474-5. PubMed ID: 10206065
[No Abstract] [Full Text] [Related]
58. The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis.
Ansaripour A; Thio HB; Maessen R; Redekop WK
J Comp Eff Res; 2017 Jun; 6(4):325-335. PubMed ID: 28452226
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic progress. II: Treatment of psoriasis.
Lewis HM
J Clin Pharm Ther; 1994 Aug; 19(4):223-32. PubMed ID: 7527403
[TBL] [Abstract][Full Text] [Related]
60. Economic burden of psoriatic patients in Japan: Analysis from a single outpatient clinic.
Takahashi H; Satoh K; Takagi A; Iizuka H
J Dermatol; 2017 Sep; 44(9):1024-1026. PubMed ID: 28406531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
